| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |